Ghazi L - Search Results

1

Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.

Ghazi L, Cohen LP, Muntner P, Shimbo D, Drawz PE. Ghazi L, et al. Hypertension. 2020 Oct;76(4):1090-1096. doi: 10.1161/HYPERTENSIONAHA.120.15300. Epub 2020 Aug 24. Hypertension. 2020. PMID: 32829666 Free PMC article. Clinical Trial.

2

Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial.

Ghazi L, O'Connor K, Yamamoto Y, Fuery M, Sen S, Samsky M, Riello RJ 3rd, Huang J, Olufade T, McDermott J, Inzucchi SE, Velazquez EJ, Wilson FP, Desai NR, Ahmad T. Ghazi L, et al. Am Heart J. 2023 Mar;257:111-119. doi: 10.1016/j.ahj.2022.12.002. Epub 2022 Dec 6. Am Heart J. 2023. PMID: 36493842 Free article. Clinical Trial.

3

Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.

Ghazi L, Dudenbostel T, Lin CP, Oparil S, Calhoun DA. Ghazi L, et al. J Hypertens. 2016 May;34(5):1005-10. doi: 10.1097/HJH.0000000000000870. J Hypertens. 2016. PMID: 26886564 Free PMC article.

4

Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.

Dudenbostel T, Ghazi L, Liu M, Li P, Oparil S, Calhoun DA. Dudenbostel T, et al. Among authors: ghazi l. Hypertension. 2016 Oct;68(4):995-1003. doi: 10.1161/HYPERTENSIONAHA.116.07806. Epub 2016 Aug 15. Hypertension. 2016. PMID: 27528066 Free PMC article.

5

BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?

Bhatt H, Ghazi L, Calhoun D, Oparil S. Bhatt H, et al. Among authors: ghazi l. Curr Cardiol Rep. 2016 Oct;18(10):98. doi: 10.1007/s11886-016-0775-0. Curr Cardiol Rep. 2016. PMID: 27566331 Review.

6

11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.

Ghazi L, Dudenbostel T, Hachem ME, Siddiqui M, Lin CP, Oparil S, Calhoun DA. Ghazi L, et al. Am J Hypertens. 2017 May 1;30(5):518-523. doi: 10.1093/ajh/hpx002. Am J Hypertens. 2017. PMID: 28180242 Free PMC article.

7

Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant.

Ghazi L, Oparil S, Calhoun DA, Lin CP, Dudenbostel T. Ghazi L, et al. Hypertension. 2017 May;69(5):827-835. doi: 10.1161/HYPERTENSIONAHA.116.08632. Epub 2017 Mar 27. Hypertension. 2017. PMID: 28348010 Free PMC article.

8

Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy.

Ghazi L, Drawz P. Ghazi L, et al. F1000Res. 2017 Mar 21;6:F1000 Faculty Rev-297. doi: 10.12688/f1000research.9692.1. eCollection 2017. F1000Res. 2017. PMID: 28413612 Free PMC article. Review.

9

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE; SPRINT Research Study Group. Soliman EZ, et al. Among authors: ghazi l. Circulation. 2017 Aug 1;136(5):440-450. doi: 10.1161/CIRCULATIONAHA.117.028441. Epub 2017 May 16. Circulation. 2017. PMID: 28512184 Free PMC article. Clinical Trial.

10

Impact of the SPRINT Trial on Hypertension Management.

Ghazi L, Oparil S. Ghazi L, et al. Annu Rev Med. 2018 Jan 29;69:81-95. doi: 10.1146/annurev-med-050416-024516. Annu Rev Med. 2018. PMID: 29414255 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page